These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2716172)

  • 21. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of free digoxin and total digoxin: extent of interference from digoxin-like immunoreactive substances (DLIS) in a fluorescence polarization assay.
    Dasgupta A; Nakamura A; Doria L; Dennen D
    Clin Chem; 1989 Feb; 35(2):323-4. PubMed ID: 2914387
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of tocolytic therapy on serum digoxin-like immunoreactive substance concentration.
    Yapar EG; Ayhan A
    Gynecol Obstet Invest; 1994; 37(1):10-3. PubMed ID: 8125400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digoxin-like immunoreactive substance in renal transplant patients.
    Schrader BJ; Maddux MS; Veremis SA; Mozes MF; Maturen A; Bauman JL
    J Clin Pharmacol; 1991 Dec; 31(12):1126-31. PubMed ID: 1662232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Chinese medicines Chan Su, Asian ginseng, Siberian ginseng, and American ginseng on a new digoxin immunoassay based on luminescent oxygen channeling technology.
    Dasgupta A; Syklawer E; Johnson M; Hwang SA; Boyd SA; Actor JK
    Ther Drug Monit; 2011 Oct; 33(5):644-8. PubMed ID: 21860344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DLIS affects digoxin interpretation.
    Lee KR; Phelps SJ
    Am Pharm; 1993 Mar; NS33(3):6. PubMed ID: 8329041
    [No Abstract]   [Full Text] [Related]  

  • 27. Digoxin-like and digitoxin-like immunoreactive substances in elderly people. Impact on therapeutic drug monitoring of digoxin and digitoxin concentrations.
    Wu SL; Li W; Wells A; Dasgupta A
    Am J Clin Pathol; 2001 Apr; 115(4):600-4. PubMed ID: 11293909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale].
    Shi YS; Liu JH; Yu XZ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):229-31. PubMed ID: 8156846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inaccuracies in digoxin measurement.
    Cook JD; Koch TR; Cook MS; Knoblock EC
    Clin Biochem; 1988 Dec; 21(6):353-7. PubMed ID: 3233747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological actions of "kyushin," a drug containing toad venom: cardiotonic and arrhythmogenic effects, and excitatory effect on respiration.
    Morishita S; Shoji M; Oguni Y; Ito C; Higuchi M; Sakanashi M
    Am J Chin Med; 1992; 20(3-4):245-56. PubMed ID: 1471608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin automated immunoassay.
    Lacarelle B; Durand A; Labadie N; Cano JP
    Ther Drug Monit; 1989 Nov; 11(6):725-7. PubMed ID: 2595757
    [No Abstract]   [Full Text] [Related]  

  • 33. Falsely elevated serum digoxin levels secondary to endogenous digoxin-like immunoreactive substances.
    Koobatian TJ; Roberts JR
    Acad Emerg Med; 1995 Apr; 2(4):322-6. PubMed ID: 11727693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range.
    Morris RG; Jones TE; Goldsworthy SJ; Wagner TJ; Ho H; Horowitz JD
    Ther Drug Monit; 2006 Jun; 28(3):454-7. PubMed ID: 16778733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous glycosides in critically ill patients.
    Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
    Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac glycosides.
    Koren G; Soldin SJ
    Clin Lab Med; 1987 Sep; 7(3):587-606. PubMed ID: 3308298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute hypotensive effect of calcium antagonists and endogenous digitalis-like immunoreactivity in human essential hypertension.
    Palombo C; Marabotti C; Genovesi-Ebert A; Del Chicca MG; Balzan S; Giaconi S; Fommei E; Gazzetti P; Clerico A; Ghione S
    J Hypertens Suppl; 1986 Dec; 4(5):S461-4. PubMed ID: 3033184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digoxin-like immunoreactive substance (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS.
    Gervais A; Nanji AA; Greenway DC; McLean W
    Drug Intell Clin Pharm; 1987 May; 21(5):450-2. PubMed ID: 3582173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating concentrations of total digoxin and digoxin-like immunoreactive substances in volume-expanded patients being treated with digoxin.
    Dasgupta A; Schammel DP; Limmany AC; Datta P
    Ther Drug Monit; 1996 Feb; 18(1):34-9. PubMed ID: 8848818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Digoxin-like immunoreactive substance in the elderly patient and its impact on the TDx digoxin assay.
    Yamamoto T; Takano K; Sanaka M; Nomura Y; Koike Y; Mineshita S
    Ther Drug Monit; 1998 Aug; 20(4):417-21. PubMed ID: 9712467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.